Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 6.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.50p
  • 52 Week Low: 5.62p
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 222,685
  • Market Cap: £27.31m
  • RiskGrade: 348
  • Beta: 0.56

Key dates

Dividend  
Latest XD Date n/a
Latest Pay Date n/a
   
Meetings  
AGM 09-Dec-2025
EGM n/a
GMs 18-Dec-2024
   
Announcements  
Trading announcement 10-Apr-2025
IMSs n/a
Drilling Report n/a
   
Results  
Final results 03-Nov-2025
Interim results 18-Mar-2025
Q1 Results 20-Nov-2024
Q2 Results 31-Mar-2022
Q3 Results 15-May-2024
Q4 Results 28-Sep-2023
Annual Report 21-Nov-2024
   
Year End n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

RENX Market Data

Currency UK Pounds
Share Price 6.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.50p
52 Week Low 5.62p
Volume 222,685
Shares Issued 437.02m
Market Cap £27.31m
Beta 0.56
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 10-Dec-2025

Time Volume / Share Price
13:31 200,000 @ 6.20p
13:30 1,513 @ 6.20p
12:48 1,572 @ 6.20p
12:09 769 @ 6.50p
11:56 1,000 @ 6.21p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page